Demographic features and health status of the study population at baseline
| Variables | n = 99 |
|---|---|
| Age (years, mean ± SEM; range) | 63.16 ± 1.28; 18–89 |
| Gender (n, %) | |
| male | 53 (54%) |
| female | 46 (46%) |
| End-stage renal disease underlying disease (n, %) | |
| glomerular diseases | 25 (25%) |
| diabetic nephropathy | 15 (15%) |
| nephrosclerosis | 15 (15%) |
| polycystic kidney | 14 (14%) |
| congenital nephropathies | 1 (1%) |
| pyelonephritis | 5 (5%) |
| hypertensive nephropathy | 7 (7%) |
| others | 9 (9%) |
| unknown | 10 (10%) |
| Type of MRD (n, %) | |
| hemodialysis | 90 (91%) |
| peritoneal dialysis | 9 (9%) |
| Duration of MRD (years, mean ± SEM) | 7.91 ± 0.71 |
| Duration of xerosis (years, mean ± SEM) | 5.4 ± 0.53 |
| Clinical severity of xerosis (n, %) | |
| mild | 2 (2%) |
| moderate | 50 (51%) |
| severe to very severe | 47 (47%) |
| Total clinical score of xerosis (mean ± SEM) | 8.3 ± 0.3 |
| Association with pruritus (n, %) | |
| yes | 74 (75%) |
| no | 25 (25%) |
| Severity of pruritus (mm VAS, mean ± SEM) | 40.64 ± 3.36 |
| Quality of life scores (mean ± SEM) | |
| PCS | 30.51 ± 1.21 |
| MCS | 41.29 ± 1.24 |
| DLQI | 5.61 ± 0.57 |